View Information Collection (IC)
View Information Collection (IC)

View Information Collection (IC)

Rapid Message Testing with Consumer Panel - Additional Testing of Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER) CDER
 
Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Interview Guide Cognitive Interview Guide.docx Yes Yes Printable Only
Other-Screener Screener.docx Yes Yes Fillable Fileable
Other-Author Manuscript Author Manuscript - Patient Understanding of Nonmedical Terms.pdf Yes Yes Printable Only
Other-Drug Safety Communication - Benadryl FDA Drug Safey Communication - Benadryl.pdf Yes Yes Printable Only
Other-Drug Safety Communication - Imodium FDA Drug Safety Communication - Imodium.pdf Yes Yes Printable Only
Other-Drug Safety Communication - Nasadrine FDA Drug Safety Communication - Nasadrine.pdf Yes Yes Printable Only

Health Consumer Health and Safety

 

750 0
   
Individuals or Households
 
   100 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 750 0 0 0 0 750
Annual IC Time Burden (Hours) 45 0 0 0 0 45
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
OMB Approval Memo 0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2021.docx 03/11/2021
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.